Matthew C. Hill - 13 Dec 2021 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Chief Financial Officer
Signature
/s/ Matthew C. Hill
Issuer symbol
PDSB
Transactions as of
13 Dec 2021
Net transactions value
+$27,860
Form type
4
Filing time
14 Dec 2021, 08:10:53 UTC
Previous filing
20 Oct 2021
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PDSB Common Stock Purchase $22,500 +2,500 +256% $9.00 3,475 13 Dec 2021 Direct F1
transaction PDSB Common Stock Purchase $3,560 +400 +12% $8.90 3,875 13 Dec 2021 Direct F1
transaction PDSB Common Stock Purchase $900 +100 +2.6% $9.00 3,975 13 Dec 2021 Son F1
transaction PDSB Common Stock Purchase $900 +100 +2.5% $9.00 4,075 13 Dec 2021 Daughter F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired on the open market.